Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1

Journal of Lipid Research

Volumn 50, Issue 5, 2009, Pages 870-879

  Rosenblat, Mira ^a   Coleman, Raymond ^a   Reddy, Srinivasa T ^b   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Macrophages; Oxidative stress; Triglycerides

Indexed keywords

ARYLDIALKYLPHOSPHATASE 2; DIACYLGLYCEROL ACYLTRANSFERASE 1; MESSENGER RNA; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ARYLDIALKYLPHOSPHATASE; DIACYLGLYCEROL ACYLTRANSFERASE; ISOENZYME; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL METABOLISM; CELL STRESS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FOAM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CYTOLOGY; ENZYMOLOGY; GENETICS; METABOLISM; MICROSOME; MOUSE MUTANT;

ANIMALS; ARYLDIALKYLPHOSPHATASE; DIACYLGLYCEROL O-ACYLTRANSFERASE; FOAM CELLS; HUMANS; ISOENZYMES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES; RECOMBINANT PROTEINS; TRIGLYCERIDES;

EID: 67649690455     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800550-JLR200     Document Type: Article

References (45)

1. Carmena, R., P. Duriez, and J. C. Fruchart. 2004. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 109: III2-III7.
2. Cullen, P. 2000. Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 86: 943-949.
3. Aviram, M., and M. Rosenblat. 2004. Paraoxonases 1, 2 and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37: 1304-1316.
4. Tiwari, R. L., Y. Singh, and M. K. Barthwal. 2008. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med. Res. Rev. 28: 483-544.
5. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
6. Lang, P. D., and W. Jr Insull. 1970. Lipid droplets in atherosclerotic fatty streaks of human aorta. J. Clin. Invest. 49: 1479-1488.
7. Lundberg, B. 1985. Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis. 56: 93-110.
8. Mattsson, L., H. Johansson, M. Ottosson, G. Bondjers, and O. Wilklund. 1993. Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J. Clin. Invest. 92: 1759-1765.
9. Botham, K. M., E. H. Moore, C. D. Pascale, and F. Bejta. 2007. The induction of macrophage foam cell formation by chylomicrons remnants. Biochem. Soc. Trans. 35: 454-458.
10. Napolitano, M., M. Avella, K. M. Botham, and E. Bravo. 2003. Chylomicrons remnant induction of lipid accumulation in J774 A.1 macrophages is associated with up-regulation of triacylglycerol synthesis which is not dependent on oxidation of the particles. Biochim. Biophys. Acta. 1631: 255-264.
11. Aronis, A., Z. Madar, and O. Tirosh. 2005. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilities mitochondrial reactive oxygen species production and cellular necrosis. Free Radic. Biol. Med. 38: 1221-1230.
12. Draganov, D. I., J. F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B. N. La Du. 2005. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 46: 1239-1247.
13. Ng, C. J., D. J. Wadleigh, A. Gangopadhyay, S. Hama, V. R. Grijalva, M. Navab, A. M. Fogelman, and S. T. Reddy. 2001. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276: 44444-44449.
14. Rosenblat, M., D. Draganov, C. E. Watson, C. L. Bisgaier, B. N. La Du, and M. Aviram. 2003. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23: 468-474.
15. Rosenblat, M., T. Hayek, K. Hussein, and M. Aviram. 2004. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler. Thromb. Vasc. Biol. 24: 175-180.
16. Fortunato, G., M. D. Di Taranto, U. M. Bracale, L. Del Guercio, F. Carbone, C. Mazzaccara, A. Morgante, F. P. D'Armiento, M. D'Armiento, M. Porcellini, et al. 2008. Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28: 594-600.
17. Ng, C. J., S. Y. Hama, N. Bourquard, M. Navab, and S. T. Reddy. 2006. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice. Mol. Genet. Metab. 89: 368-373.
18. Ng, C. J., N. Bourquard, V. R. Grijalva, S. Hama, D. M. Shih, M. Navab, A. M. Fogelman, A. J. Lusis, S. Young, and S. T. Reddy. 2006. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: antiatherogenic role for paraoxonase-2. J. Biol. Chem. 281: 29491-29500.
19. Horke, S., I. Witte, P. Wilgenbus, M. Krüger, D. Strand, and U. Förstermann. 2007. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation. 115: 2055-2064.
20. Shiner, M., B. Fuhrman, and M. Aviram. 2006. A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. Biochem. Biophys. Res. Commun. 349: 1094-1099.
21. Shiner, M., B. Fuhrman, and M. Aviram. 2004. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages. Free Radic. Biol. Med. 37: 2052-2063.
22. Shiner, M., B. Fuhrman, and M. Aviram. 2007. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. Atherosclerosis. 195: 313-321.
23. Shiner, M., B. Fuhrman, and M. Aviram. 2007. Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Biol. Chem. 388: 1353-1358.
24. Fuhrman, B., J. Khateeb, M. Shiner, O. Nitzan, R. Karry, N. Volkova, and M. Aviram. 2008. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 28: 1361-1367.
25. Coleman, R., T. Hayek, S. Kiar, and M. Aviram. 2006. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient E (0) mice. Acta Histochem. 108: 415-424.
26. Neuhuber, B., D. I. Huang, M. P. Daniels, and C. E. Torgan. 2002. High efficiency transfection of primary skeletal muscle cells with lipid-based reagents. Muscle Nerve. 26: 136-140.
27. Hellgren, I., V. Drvota, R. Pieper, S. Enoksson, P. Biomberg, K. B. Islam, and C. Sylven. 2000. Highly efficient cell-mediated gene transfer using non-viral vectors and Fugene6: in vitro and in vivo studies. Cell. Mol. Life Sci. 57: 1326-1333.
28. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
29. Vaziri, N. D., C. H. Kim, D. Phan, S. Kim, and K. Liang. 2004. Upregulation of hepatic acylCoA:diacylglycerol acyltransferase-1 (DGAT1) expression in neophrotic syndrome. Kidney Int. 66: 262-267.
30. El-Saadani, M., N. Esterbauer, M. El-Sayed, M. Goher, A. Y. Nassar, and G. Jurgens. 1989. Spectrophotometric assay for lipid peroxides in serum lipoproteins using commercially available reagent. J. Lipid Res. 30: 627-630.
31. Farese, R. V., Jr., S. Cases, and S. J. Smith. 2000. Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase. Curr. Opin. Lipidol. 11: 229-234.
32. Cases, S., S. J. Smith, Y-W. Zheng, H. M. Myers, S. R. Lear, E. Sande, S. Nivak, C. Collins, C. B. Welch, A. J. Lusis, et al. 1998. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. USA. 95: 13018-13023.
33. Cases, S., S. J. Stone, P. Zhou, E. Yen, B. Tow, K. D. Lardizabal, T. Voelker, and R. V. Farese, Jr. 2001. Cloning of DGAT2: a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276: 38870-38876.
34. Moore, E. H., M. Napolitano, A. Prosperi, M. Avella, K. E. Suckling, E. Bravo, and K. M. Botham. 2003. Incorporation of lycopene into chylomicron remnant-like particles enhances their induction of lipid accumulation in macrophages. Biochem. Biophys. Res. Commun. 312: 1216-1219.
35. Dat, N. T., X. F. Cai, M. C. Rho, H. S. Lee, K. Bae, and Y. H. Kim. 2005. The inhibition of diacylglycerol acyltransferase by terpenoids from Youngia koidzumiana. Arch. Pharm. Res. 28: 164-168.
36. Frei, B., R. Stocker, and B. N. Ames. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85: 9748-9752.
37. Lehner, R., and A. Kusis. 1996. Biosynthesis of triacylglycerol. Prog. Lipid Res. 35: 169-201.
38. Coleman, R. A., and D. P. Lee. 2004. Enzymes of triacylglycerol synthesis and their regulation. Prog. Lipid Res. 43: 134-176.
39. Yu, Y. H., Y. Zhang, P. Olelkers, S. L. Sturley, D. J. Rader, and H. N. Ginsberg. 2002. Posttranscriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes. J. Biol. Chem. 277: 50876-50884.
40. Casaschi, A., G. K. Maiyoh, K. Adeli, and A. G. Theriault. 2005. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters. Metabolism. 54: 403-409.
41. Van Der Vlies, D., M. Makkinje, A. Jansens, I. Braakman, A. J. Verkleij, K. W. A. Wirtz, and J. A. Post. 2003. Oxidation of ER resident proteins upon oxidative stress: effects of altering cellular redox/antioxidant status and implications for protein maturation. Antioxid. Redox Signal. 5: 381-387.
42. Kaplán, P., M. Doval, Z. Majerová, J. Lehotský, and P. Racay. 2000. Iron-induced lipid peroxidation and protein modification in endoplasmic reticulum membranes. Protection by stobadine. Int. J. Biochem. Cell Biol. 32: 539-547.
43. Van Der Vlies, D., E. H. W. Pap, J. A. Post, J. E. Celis, and K. W. A. Wirtz. 2002. Endoplasmic reticulum resident proteins of normal human dermal fibroblasts are the major targets for oxidative stress induced by hydrogen peroxide. Biochem. J. 366: 825-830.
44. Pallottini, V., C. Martini, A. Pascolini, G. Cavallini, Z. Gori, E. Bergamini, S. Incerpi, and A. Trentalance. 2005. 3-Hydroxy-3-methylglutaryl coenzyme A reductase deregulation and age-related hypercholesterolemia: a new role for ROS. Mech. Ageing Dev. 126: 845-851.
45. Pallottini, V., C. Martini, G. Cavallini, E. Bergamini, K. J. Mustard, D. G. Hardie, and A. Trentalance. 2007. Age-related HMG-CoA reductase deregulation depends on ROS-induced p38 activation. Mech. Ageing Dev. 128: 688-695.